Product Description
Mechanisms of Action:
Novel Mechanism: No
Modality: Small Molecule
Route of Administration: Topical, Vaginal
FDA Designation: *
Approval Status: Not Approved
Approved Countries: Argentina | Australia | Austria | Brazil | Canada | Chile | China | Croatia | Czech | Denmark | Dominican Republic | Ecuador | Estonia | European Medicines Agency | Finland | Greece | Hong Kong | Hungary | Iceland | India | Indonesia | Ireland | Israel | Italy | Jordan | Korea | Latvia | Lithuania | Malta | Mexico | New Zealand | Pakistan | Peru | Philippines | Poland | Portugal | Serbia | Singapore | Slovakia | Slovenia | Spain | Sweden | Taiwan | Thailand | Turkey | Ukraine | United States | Venezuela
Approved Indications: None
Known Adverse Events: None
Company: None
Company Location:
Company CEO:
Additional Commercial Interests: None
Clinical Description
Countries in Clinic:
Active Clinical Trial Count:
Recent & Upcoming Milestones
Highest Development Phases
Trial |
Phase |
Trial Status |
Disease |
Primary Completion Date |
Probability of Success |
Latest Trial Update Date |
Data Updated |
|---|